25
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Accelerating the SDG3 Global Action Plan

      editorial
      1 , , 2 , 1
      BMJ Global Health
      BMJ Publishing Group
      Health policy, Health systems

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Four years after the adoption of the Agenda 2030, the implementation of the Sustainable Development Goal 3 (SDG3) ‘to ensure healthy lives and well-being for all’ is delayed, limited and stalling. In 2018, political leaders from Ghana, Norway and Germany requested the WHO and other global health-related institutions to develop a ‘Global Action Plan for Healthy Lives and Well-being for All (SDG3 GAP).’1 Yet challenges impede the SDG3 GAP’s development and implementation. The activities of numerous states and non-state actors in global health are not well coordinated and there is no accepted leadership. Global health actors are fragmented and still largely organised to meet the Millennium Development Goals (MDGs).2 It is assumed that SDG3 GAP signatories’ untapped synergies simply need to be better coordinated to achieve SDG3. Instead, global health governance requires a disruptive reform.3 We believe the SDG3 GAP could lay the groundwork for such a shift. Launched in October 2018, the SDG3 GAP has been organised around three objectives: to (1) align efforts of all signatories; (2) accelerate progress; and (3) account their collective results.4 Recently, a fourth ‘A’ to assess was added and an open consultation process conducted. Interested stakeholders were invited to comment on the plan and propose improvements.5 We think the SDG3 GAP can accelerate SDG3 implementation and at the same time be an instrument to explore global health governance reform. It can complement and harmonise strategies and investment cases to accelerate achieving SDG3. Yet we fear the plan, as it is currently conceptualised, perpetuates existing challenges, power relations and misses opportunities to transform global health governance. Accordingly, we offer feedback along the latest Quadruple-A approach. 1. Assess: Harmonising signatories’ different strategic approaches towards the SDGs will be a major challenge, particularly as the global political environment makes governance shifts unlikely. A preliminary comparison between the health-related SDG targets and indicators reveals gaps, for example, in terms of addressing non-communicable diseases. The GAP could add value by highlighting under represented and underfunded areas within organisations and enabling new programmes, targeting advocacy as well as reform and/or consolidation. It will be critical for the plan’s success to identify gaps and suggest solutions to enable global health governance reform. Country-driven, honest dialogues between relevant actors about their shared but also conflicting interests should be the point of departure. 2. Align: The SDG3 GAP process includes a number of so-called accelerators; however, the accelerators do not necessarily reflect the views or ongoing efforts of all signatories. An initial analysis reveals contradictions between the accelerators and SDG3 targets, which seem to represent institutional priorities rather than SDG3 targets. For example, the accelerator on sustainable financing emphasises the detection, containment and prevention of infectious diseases (pandemic preparedness) to the detriment of a focus on building health systems (SDG3.8, which focuses on achieving universal health coverage). This merits further analysis and discussions. Alignment must succeed at the global and national levels with countries in the lead. 3. Accelerate: Collective and coordinated effort by the signatories is key. Those actions must balance added value of the plan at national level with the transaction cost to assess, align, accelerate and account. Critical SDG3 components are overlooked: for example, human resources for health and antimicrobial resistance. Aligning the GAP with existing strategies, road maps, frameworks and platforms is an opportunity to link the GAP to SDG3 and other thematic initiatives and therefore minimises risk of further verticalisation. The accelerators’ content and foci should not distort national priorities. At the national level, focal points, bottom-up consultation and decision-making processes as well as governance research for all plan-related matters could support the plan’s implementation. Financing the GAP could also be discussed at the United Nations High-Level Meeting on Universal Health Coverage in September. 4. Account: Governments should insist on a shared mechanism to account for the signatories’ collective results, by using disaggregated data and allowing feedback from civil society. Transparency regarding the continuing development of the plan and the accelerators as well as their implementation should be fostered. This includes establishing mechanisms for civil society and community engagement. Furthermore, the proposed midpoint milestones could be used to assess health-related SDG indicators’ alignment across organisations and between global and country levels. In many cases, national SDG implementation mechanisms already exist to ensure SDG incorporation into national policies and could be further leveraged. As part of the SDG3 GAP to be launched in September, a commitment for reviewing progress with an annual road map should be part of these efforts. Moving forward, countries should use this road map to leverage their financial and structural influence, if necessary in an ‘SDG3 Alliance of the Willing,’ to reshape and reform the existing MDG global health architecture. After September, the GAP should take note of comparative advantages of each signatory and answer the question of what realistically will and can change at the country level and how this will be implemented to help countries accelerate progress towards SDG3.

          Related collections

          Most cited references1

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Shifting global health governance towards the sustainable development goals

          The definition of global health governance is the use of formal and informal institutions, rules and processes by states, intergovernmental organizations and non-state actors to deal with health challenges that require effective cross-border collective actions. 1 Since 2000, global health governance processes and financing allocations have largely focused on the millennium development goals (MDGs). Three out of the eight MDGs related directly to health, and the other five goals focused on critical determinants of health. The MDGs increased aid flows, particularly for health. 2 In the early 2000s, two new funding organizations, the Global Fund to Fight AIDS, Tuberculosis and Malaria, and Gavi, the Vaccine Alliance, were created to help finance the health MDGs. Around the same time, the President’s Emergency Plan for AIDS Relief was created, with originally a five-year, 15 billion United States dollars (US$) commitment. By 2014, roughly US$ 23 billion out of a total of US$ 36 billion, or almost two-thirds of development assistance for health, were directed towards the MDGs. 3 Efforts to reach the MDG health targets dominated global health governance and reduced policy space, and accompanying financial allocations, for the consideration of other health challenges. The MDG era also brought an expanding academic interest in the field of global health and global health governance. The MDGs made a critical and often overlooked contribution to the conceptualization of global health, creating a normative global health agenda that continues to be reflected in the current architecture and financing of global health governance. 5 While building on the MDGs, the sustainable development goals (SDGs) reflect a significant enlargement for the development agenda and present an opportunity to expand the scope of global health governance. Transforming our world: the 2030 agenda for sustainable development positions health as a broad development issue. We argue that despite a major broadening of the focus for health there have been no reforms to global health governance. Global health governance is still mostly intended to deliver the MDGs, not the SDGs. The SDGs, and specifically SDG 3, that is, to ensure healthy lives and promote well-being for all at all ages, require a paradigm shift in global health. 5 This has not happened. No notable institutional, structural or financial reforms to global health governance to achieve the SDGs have taken place, and donors have not shifted their financing efforts. New health financing mechanisms are still being established to advance the unfinished MDG agenda, such as the Global Financing Facility for Every Woman Every Child (established in July 2015), which focuses on reproductive, maternal, newborn, child and adolescent health. Without any reference to the SDGs, in 2015, donors committed US$ 7.5 billion to Gavi, the Vaccine Alliance for immunization and the Global Fund’s replenishment conference in late 2016 saw donor pledges of an additional US$ 12.9 billion for HIV, tuberculosis and malaria. The World Health Organization (WHO) programme budget for 2018–2019 allocates US$ 805 million for communicable diseases in comparison to US$ 351 million for noncommunicable diseases. 6 While efforts to meet the MDG-related health goals should obviously continue, more serious efforts and focus are now needed to meet SDG 3. With its thirteenth general programme of work, 7 WHO has an opportunity to lead not just on achieving health security and universal health coverage, but also to define a clear strategy to promote health in sectors beyond and outside the health sector. However, this opportunity to reform and focus on SDG 3 cannot and should not be limited to WHO. 8 Existing institutions, financial allocations and policy processes across the field of global health will need to be rethought to meet SDG 3. With the shift from the MDGs to a more comprehensive and integrated 2030 Agenda, the SDGs will require broader financing and effective work across several sectors throughout national and global governance. Increased efforts to regulate and control risk factors for noncommunicable diseases, such as alcohol and tobacco, will also be needed. These products, 9 , 10 as well as foods high in fat, salt and sugar, 11 are increasingly consumed, but development planning, budgeting and financing rarely considers how to address these challenges and their health implications. While Phase One of the Global Action Plan for SDG 3 is ongoing, this new effort should enable assessing progress on all SDG 3 targets and the health-related indicators of other SDGs. The analysis for this Global Action Plan should suggest new reforms in governance, leadership and a reprioritization of financing. For global health governance, this will require approaching SDG 3 holistically rather than by individual targets, diseases or programmes and moving beyond the MDG health agenda. Existing institutions and financing instruments must be significantly reformed and if necessary, repurposed.
            Bookmark

            Author and article information

            Journal
            BMJ Glob Health
            BMJ Glob Health
            bmjgh
            bmjgh
            BMJ Global Health
            BMJ Publishing Group (BMA House, Tavistock Square, London, WC1H 9JR )
            2059-7908
            2019
            6 September 2019
            : 4
            : 5
            : e001930
            Affiliations
            [1 ] departmentGloabl Issues Division , German Institute for International and Security Affairs , Berlin, Germany
            [2 ] departmentGlobal Health and Development , London School of Hygiene and Tropical Medicine, Faculty of Policy and Planning , London, UK
            Author notes
            [Correspondence to ] Maike Voss; maike.voss@ 123456swp-berlin.org
            Author information
            http://orcid.org/0000-0002-7534-6722
            Article
            bmjgh-2019-001930
            10.1136/bmjgh-2019-001930
            6747908
            4d07a249-29bd-4f09-8a0b-37050cadb7c6
            © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

            This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

            History
            : 21 August 2019
            : 27 August 2019
            Categories
            Editorial
            1506
            Custom metadata
            unlocked

            health policy,health systems
            health policy, health systems

            Comments

            Comment on this article